Sangui Biotech International Inc
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and woun… Read more
Market Cap & Net Worth: Sangui Biotech International Inc (SGBI)
Sangui Biotech International Inc (PINK:SGBI) has a market capitalization of $41.98K ($41.98K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #42847 globally and #13797 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sangui Biotech International Inc's stock price $0.00 by its total outstanding shares 209902000 (209.90 Million).
Sangui Biotech International Inc Market Cap History: 2015 to 2025
Sangui Biotech International Inc's market capitalization history from 2015 to 2025. Data shows change from $4.20 Million to $41.98K (-41.16% CAGR).
Sangui Biotech International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sangui Biotech International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.36x
Sangui Biotech International Inc's market cap is 2.36 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.20 Million | $127.47K | -$704.70K | 32.93x | N/A |
| 2016 | $4.20 Million | $48.01K | -$422.27K | 87.44x | N/A |
| 2017 | $5.46 Million | $67.65K | -$308.98K | 80.67x | N/A |
| 2018 | $4.64 Million | $77.15K | -$201.81K | 60.13x | N/A |
| 2019 | $2.20 Million | $88.00K | -$316.77K | 25.04x | N/A |
| 2020 | $5.25 Million | $28.91K | -$192.74K | 181.48x | N/A |
| 2021 | $2.14 Million | $65.58K | -$235.98K | 32.64x | N/A |
| 2022 | $923.57K | $69.19K | -$59.31K | 13.35x | N/A |
| 2023 | $608.72K | $93.04K | -$147.72K | 6.54x | N/A |
| 2024 | $314.85K | $133.34K | -$12.14K | 2.36x | N/A |
Competitor Companies of SGBI by Market Capitalization
Companies near Sangui Biotech International Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Sangui Biotech International Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Sangui Biotech International Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Sangui Biotech International Inc's market cap moved from $4.20 Million to $ 41.98K, with a yearly change of -41.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $41.98K | -86.67% |
| 2024 | $314.85K | -48.28% |
| 2023 | $608.72K | -34.09% |
| 2022 | $923.57K | -56.86% |
| 2021 | $2.14 Million | -59.20% |
| 2020 | $5.25 Million | +138.10% |
| 2019 | $2.20 Million | -52.49% |
| 2018 | $4.64 Million | -15.00% |
| 2017 | $5.46 Million | +30.00% |
| 2016 | $4.20 Million | 0.00% |
| 2015 | $4.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sangui Biotech International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.98K USD |
| MoneyControl | $41.98K USD |
| MarketWatch | $41.98K USD |
| marketcap.company | $41.98K USD |
| Reuters | $41.98K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.